Report: Moderna COVID-19 Vaccine Trial Delayed

Report: Moderna COVID-19 Vaccine Trial Delayed

According to a report published Thursday on biotech industry news site STAT, citing investigators presumably involved in the research, a phase 3 clinical trial of Moderna's (NASDAQ: MRNA) mRNA-1273 has been delayed. This delay, the length of which was not specified, is due to the fact that Moderna is modifying the protocol of the research. The phase 3 trial, involving around 30,000 patients, was to begin this month.